These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39179147)

  • 1. Chemical coverage of human biological pathways.
    Kwak HA; Liu L; Tredup C; Röhm S; Prinos P; Böttcher J; Schapira M
    Drug Discov Today; 2024 Oct; 29(10):104144. PubMed ID: 39179147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoproteomics and Chemical Probes for Target Discovery.
    Drewes G; Knapp S
    Trends Biotechnol; 2018 Dec; 36(12):1275-1286. PubMed ID: 30017093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making the Case for Functional Proteomics.
    Perkins RC
    Methods Mol Biol; 2019; 1871():1-40. PubMed ID: 30276729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based approaches in drug discovery and early development.
    Harrold JM; Ramanathan M; Mager DE
    Clin Pharmacol Ther; 2013 Dec; 94(6):651-8. PubMed ID: 24025802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R; Thepaut C; Zhang H; Arends R; Stebbing J; Giamas G
    Cancer Lett; 2016 Nov; 382(1):86-94. PubMed ID: 26850375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical biology approaches to target validation in cancer.
    Blagg J; Workman P
    Curr Opin Pharmacol; 2014 Aug; 17():87-100. PubMed ID: 25175311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation.
    Artemov A; Aliper A; Korzinkin M; Lezhnina K; Jellen L; Zhukov N; Roumiantsev S; Gaifullin N; Zhavoronkov A; Borisov N; Buzdin A
    Oncotarget; 2015 Oct; 6(30):29347-56. PubMed ID: 26320181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity-oriented synthetic strategies applied to cancer chemical biology and drug discovery.
    Collins I; Jones AM
    Molecules; 2014 Oct; 19(11):17221-55. PubMed ID: 25350364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of chemogenomic library screening in drug discovery.
    Jones LH; Bunnage ME
    Nat Rev Drug Discov; 2017 Apr; 16(4):285-296. PubMed ID: 28104905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging big data to transform target selection and drug discovery.
    Chen B; Butte AJ
    Clin Pharmacol Ther; 2016 Mar; 99(3):285-97. PubMed ID: 26659699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.
    Yang H; Qin C; Li YH; Tao L; Zhou J; Yu CY; Xu F; Chen Z; Zhu F; Chen YZ
    Nucleic Acids Res; 2016 Jan; 44(D1):D1069-74. PubMed ID: 26578601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target Identification Using Chemical Probes.
    Moustakim M; Felce SL; Zaarour N; Farnie G; McCann FE; Brennan PE
    Methods Enzymol; 2018; 610():27-58. PubMed ID: 30390803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation.
    Liu Y; Platchek M; Kement B; Bee WT; Truong M; Zeng X; Hung S; Lin H; Morrow D; Kallal LA; Xie Q; Agarwal P; Pope AJ; Wu Z
    Mol Biosyst; 2014 Feb; 10(2):251-7. PubMed ID: 24257700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using artificial intelligence methods to speed up drug discovery.
    Álvarez-Machancoses Ó; Fernández-Martínez JL
    Expert Opin Drug Discov; 2019 Aug; 14(8):769-777. PubMed ID: 31140873
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting kinase inhibitors using bioactivity matrix derived informer sets.
    Zhang H; Ericksen SS; Lee CP; Ananiev GE; Wlodarchak N; Yu P; Mitchell JC; Gitter A; Wright SJ; Hoffmann FM; Wildman SA; Newton MA
    PLoS Comput Biol; 2019 Aug; 15(8):e1006813. PubMed ID: 31381559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal Chemistry.
    Deprez B; Bosc D; Charton J; Couturier C; Deprez-Poulain R; Flipo M; Leroux F; Villemagne B; Willand N
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in applications of activity-based chemical probes in the characterization of amino acid reactivities].
    Li J; Wang G; Ye M; Qin H
    Se Pu; 2023 Jan; 41(1):14-23. PubMed ID: 36633073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimagining Druggability Using Chemoproteomic Platforms.
    Spradlin JN; Zhang E; Nomura DK
    Acc Chem Res; 2021 Apr; 54(7):1801-1813. PubMed ID: 33733731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.